Research in Medical and Dental Sciences We are dedicated to performing world-leading research with the ultimate goal of improving human health.
Cancer and Genomics Combining anti-tumour drugs with chemo may improve rare children’s cancer outcomes Phase 2 trial found adding Bevacizumab to different chemotherapy drugs led to more patients’ tumours shrinking, which has helped to change routine UK treatment.
Microbiology and Infection New and highly infectious E. coli strain resistant to powerful antibiotics
Applied Health Research Lockdown air quality boost in Oxford helped 41% reduction in adult asthma hospital stays
Immunology and Immunotherapy Immune cells lose ‘killer instinct’ in cancerous tumours – but functionality can be re-awakened
International Research and Engagement Our thriving international community of researchers save and improve lives across the world.
01 March 2024 Women need better care to avoid endometrial cancer development, study finds Study follows 26 years of research conducted at University of Birmingham to establish best treatments for endometrial hyperplasia
29 February 2024 New recommendations make it easier for patients to feed back on their health A new resource may help minimise respondent burden in the collection of patient-reported outcomes.
29 February 2024 Improving screening in underrepresented groups for genetic condition with heart complications Birmingham researchers are working with community groups to help boost screening and diagnosis of a rare genetic condition in under-represented groups.
23 February 2024 Fibroblast cells play a key role in resolving joint inflammation, new study finds The discovery may open up new avenues for treatment for arthritis patients
15 February 2024 Professor Adam Croft appointed as Versus Arthritis Chair of Rheumatology Professor Adam Croft announced as the new Versus Arthritis Chair of Rheumatology and Head of the Rheumatology Research group at the University of Birmingham.
15 February 2024 Stopping the awakening of sleeping Acute Myeloid Leukaemia stem cells to prevent disease relapse New study provides clues to why leukaemic stem cells not harmed by chemotherapy begin to grow and produce AML cells after treatment.
14 February 2024 Further funding for new device to improve treatment of anal fistula The award will fund a clinical study across 10 UK hospitals to demonstrate clinical safety and healing endpoints in over 100 patients.
14 February 2024 First Patient treated in LIBERATE trial evaluating glenzocimab for heart attacks Partnership agreement with Acticor Biotech sees first patient treated in the LIBERATE clinical study to evaluate glenzocimab efficacy in myocardial infarction.
13 February 2024 Cost-effective to routinely change surgical gloves and instruments as well as being safer Results of economic analysis of ChEETAh trial looks at evidence from seven low and middle-income countries